What is the ticker symbol for Propanc Biopharma?

Propanc Biopharma trades under the ticker PPCB on NASDAQ.

What sector does Propanc Biopharma operate in?

Propanc Biopharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PPCB in a portfolio?

PortView shows PPCB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Propanc Biopharma (PPCB) Stock Analysis

NASDAQHealthcareBiotechnology

$1.09-3.54%

1-year price historyRange $0.99 – $62.75

52-week range$1.09

$0.95$70.39

What Propanc Biopharma does

Propanc Biopharma, Inc. (PPCB) is an Australian biopharmaceutical firm dedicated to developing innovative treatments for various cancers, with a particular focus on pancreatic, ovarian, and colorectal malignancies. The company's leading therapeutic candidate, PRP, is a unique formulation currently in the preclinical stage of development. This product is designed to enhance the effectiveness of multiple enzymes that work together to combat cancer. Propanc Biopharma is also engaged in a collaborative research effort with the University of Jaén, initiating the POP1 joint drug discovery program. Founded in 2007, the entity was originally known as Propanc Health Group Corporation before officially changing its name to Propanc Biopharma, Inc. in April 2017. The company's headquarters are located in Camberwell, Australia.

Key metrics

Market cap

$2.48M

P/E (TTM)

-0.14

EPS (TTM)

$-8.04

Beta

3.27

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.37

200-day avg

$5.92

52-week high

$70.39

52-week low

$0.95

CEO

James Nathanielsz

ETFs linked to PPCB

Broad-market and Healthcare sector ETFs an investor holding Propanc Biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PPCB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PPCB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Propanc Biopharma?: Propanc Biopharma trades under the ticker PPCB on NASDAQ.
Which exchange is PPCB listed on?: PPCB is listed on NASDAQ.
What sector does Propanc Biopharma operate in?: Propanc Biopharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PPCB in a portfolio?: PortView shows PPCB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.